Real-time enrollment status for this hypereosinophilic syndrome clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 5:01 AM UTC
| NCT Number | NCT05334368 |
| Recruiting Status | Recruiting |
| Condition | Hypereosinophilic Syndrome |
| Phase | PHASE3 |
| Target Enrollment | 123 participants |
| Active Locations | 11 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | November 25, 2025 (Nov 25, 2025) |
As of July 19, 2026: Clinical trial NCT05334368 is currently recruiting participants. This phase3 study for hypereosinophilic syndrome is actively seeking new participants at 11 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05334368 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05334368 was last updated Nov 25, 2025 (November 25, 2025). HelloStudys verifies this status automatically.